CRL Q2 2022 Earnings Report — Charles River Laboratories International, Inc. Revenue & Financial Results | Market Cap Arena

Charles River Laboratories International, Inc.CRL

Q2 2022 Earnings

Reported August 3, 2022

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	Q2 2022	Q1 2022	Q2 2021	QoQ Change	YoY Change
Revenue	$973M	—	—	—	—
Op. Income	$187M	—	—	—	—
Gross Margin	36.7%	—	—	—	—
Net Margin	11.2%	—	—	—	—
EPS (Diluted)	$2.13	—	—	—	—
Free Cash Flow	$67M	—	—	—	—

Revenue Flow

Item	Amount
REVENUE	$973M
Cost of Revenue	$616M
GROSS PROFIT	$357M
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$132M
Other Expenses	$38M
Operating Expenses	$169M
Cost & Expenses	$786M
OPERATING INCOME	$187M
Interest Income	$188.0K
Interest Expense	$4M
Other Income/Expenses	-$43M
INCOME BEFORE TAX	$144M
Income Tax Expense	$33M
Net Income from Continuing Ops	$111M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$109M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$109M
D&A	$76M
EBIT	$148M
EBITDA	$224M
EPS	$2
EPS Diluted	$2

Income Statement

Item	Amount
REVENUE	$973M
Cost of Revenue	$616M
GROSS PROFIT	$357M
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$132M
Other Expenses	$38M
Operating Expenses	$169M
Cost & Expenses	$786M
OPERATING INCOME	$187M
Interest Income	$188.0K
Interest Expense	$4M
Other Income/Expenses	-$43M
INCOME BEFORE TAX	$144M
Income Tax Expense	$33M
Net Income from Continuing Ops	$111M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$109M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$109M
D&A	$76M
EBIT	$148M
EBITDA	$224M
EPS	$2
EPS Diluted	$2

Cash Flow Statement

Item	Amount
Net Income	$109M
Depreciation & Amortization	$76M
Stock-Based Compensation	$15M
Deferred Income Tax	-$7M
Other Non-Cash Items	$8M
Change in Working Capital	-$52M
OPERATING CASH FLOW	$149M
Capital Expenditure	-$83M
Acquisitions (Net)	-$283M
Purchases of Investments	-$96M
Sales/Maturities of Investments	$0
Other Investing Activities	-$324.0K
NET CASH FROM INVESTING	-$462M
Net Debt Issuance	$311M
Common Stock Repurchased	-$4M
Common Dividends Paid	$0
Other Financing Activities	-$35M
NET CASH FROM FINANCING	$271M
FREE CASH FLOW	$67M
Net Change in Cash	-$36M

Balance Sheet

Item	Amount
Cash & Equivalents	$206M
Short-Term Investments	$1M
Net Receivables	$755M
Inventory	$257M
Other Current Assets	$0
TOTAL CURRENT ASSETS	$1.4B
PP&E (Net)	$1.8B
Goodwill	$2.9B
Intangible Assets	$1.0B
Long-Term Investments	$280M
Tax Assets	$42M
Other Non-Current Assets	$155M
TOTAL NON-CURRENT ASSETS	$6.1B
TOTAL ASSETS	$7.5B
Account Payables	$211M
Short-Term Debt	$95.0K
Deferred Revenue	$242M
Other Current Liabilities	$294M
TOTAL CURRENT LIABILITIES	$1.0B
Long-Term Debt	$3.0B
Deferred Revenue NC	$21M
Deferred Tax Liabilities	$230M
Other Non-Current Liabilities	$174M
TOTAL NON-CURRENT LIABILITIES	$3.8B
TOTAL LIABILITIES	$4.8B
Common Stock	$510.0K
Additional Paid-In Capital	$1.8B
Retained Earnings	$1.2B
Treasury Stock	-$38M
Accum. Other Comp. Income	-$259M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$2.6B
Minority Interest	$45M
TOTAL EQUITY	$2.7B
TOTAL LIABILITIES & EQUITY	$7.5B
Total Debt	$3.4B
Net Debt	$3.2B